Khalid Abubaker

1.3k total citations
14 papers, 1.1k citations indexed

About

Khalid Abubaker is a scholar working on Oncology, Reproductive Medicine and Neurology. According to data from OpenAlex, Khalid Abubaker has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Reproductive Medicine and 3 papers in Neurology. Recurrent topics in Khalid Abubaker's work include Ovarian cancer diagnosis and treatment (8 papers), Cancer Cells and Metastasis (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Khalid Abubaker is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Cancer Cells and Metastasis (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Khalid Abubaker collaborates with scholars based in Australia, United States and Ireland. Khalid Abubaker's co-authors include Nuzhat Ahmed, Michael Quinn, Jock K. Findlay, Erik W. Thompson, J. K. Findlay, Ardian Latifi, Rodney B. Luwor, Hong‐Jian Zhu, Simon Nazaretian and Ciarán Bolger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Khalid Abubaker

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Abubaker Australia 10 572 560 308 212 142 14 1.1k
Esther S.Y. Wong Hong Kong 15 345 0.6× 749 1.3× 190 0.6× 89 0.4× 23 0.2× 20 1.0k
Terje Ahlquist Norway 16 430 0.8× 567 1.0× 301 1.0× 49 0.2× 101 0.7× 20 1.2k
Kimberly A. Scata United States 8 270 0.5× 554 1.0× 192 0.6× 53 0.3× 34 0.2× 10 765
Shiwu Wu China 19 353 0.6× 546 1.0× 303 1.0× 27 0.1× 33 0.2× 61 871
Caroline H. Diep United States 11 574 1.0× 376 0.7× 191 0.6× 85 0.4× 10 0.1× 15 1.1k
N. Shishido United States 3 839 1.5× 974 1.7× 152 0.5× 25 0.1× 35 0.2× 5 1.4k
Anna G. Antonacopoulou Greece 21 457 0.8× 529 0.9× 257 0.8× 19 0.1× 30 0.2× 50 1.0k
Marie E. Beckner United States 16 146 0.3× 392 0.7× 209 0.7× 41 0.2× 28 0.2× 32 764
Alexander Gheldof Belgium 11 437 0.8× 660 1.2× 285 0.9× 74 0.3× 7 0.0× 26 1.1k

Countries citing papers authored by Khalid Abubaker

Since Specialization
Citations

This map shows the geographic impact of Khalid Abubaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Abubaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Abubaker more than expected).

Fields of papers citing papers by Khalid Abubaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Abubaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Abubaker. The network helps show where Khalid Abubaker may publish in the future.

Co-authorship network of co-authors of Khalid Abubaker

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Abubaker. A scholar is included among the top collaborators of Khalid Abubaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Abubaker. Khalid Abubaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Abubaker, Khalid, Danyi Wang, Zheng Feng, et al.. (2022). Abstract 5245: Characterization of sub-clonal RAS/BRAF alterations in an anti-EGFR treated advanced CRC cohort using a liquid biopsy-based real world clinical genomics database. Cancer Research. 82(12_Supplement). 5245–5245. 1 indexed citations
2.
Bekaii‐Saab, Tanios, Eric Van Cutsem, Antonio Cubillo, et al.. (2021). PERSPECTIVE: Tepotinib + cetuximab in patients (pts) with RAS/BRAF wild-type left-sided metastatic colorectal cancer (mCRC) and acquired resistance to anti-EGFR antibody therapy due to MET amplification (METamp).. Journal of Clinical Oncology. 39(15_suppl). TPS3616–TPS3616. 4 indexed citations
3.
Abubaker, Khalid, Ardian Latifi, Emily Chan, et al.. (2015). Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics. Monash University Research Portal (Monash University). 3(1). 1–1. 7 indexed citations
4.
5.
Abubaker, Khalid, Rodney B. Luwor, Ruth M. Escalona, et al.. (2014). Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden. Frontiers in Oncology. 4. 75–75. 9 indexed citations
6.
Abubaker, Khalid, Rodney B. Luwor, Hong‐Jian Zhu, et al.. (2014). Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer. 14(1). 317–317. 103 indexed citations
7.
Friedrich, Benjamin, et al.. (2014). CO2 Has no Therapeutic Effect on Early Micro Vasospasm after Experimental Subarachnoid Hemorrhage. Journal of Cerebral Blood Flow & Metabolism. 34(8). e1–e6. 26 indexed citations
8.
Ahmed, Nuzhat, Khalid Abubaker, & Jock K. Findlay. (2013). Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets. Molecular Aspects of Medicine. 39. 110–125. 71 indexed citations
9.
Abubaker, Khalid, Ardian Latifi, Rodney B. Luwor, et al.. (2013). Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Molecular Cancer. 12(1). 24–24. 177 indexed citations
10.
Ahmed, Nuzhat, Khalid Abubaker, Jock K. Findlay, & Michael Quinn. (2012). Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance. Journal of Cellular Biochemistry. 114(1). 21–34. 88 indexed citations
11.
Latifi, Ardian, Khalid Abubaker, Alister C. Ward, et al.. (2011). Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. Journal of Cellular Biochemistry. 112(10). 2850–2864. 212 indexed citations
12.
Abubaker, Khalid, et al.. (2011). Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts – case series and literature review. British Journal of Neurosurgery. 25(1). 94–99. 115 indexed citations
13.
Ahmed, Nuzhat, Khalid Abubaker, J. K. Findlay, & Michael Quinn. (2010). Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer. Current Cancer Drug Targets. 10(3). 268–278. 199 indexed citations
14.
Wong, Limy, Khalid Abubaker, Jane Cryan, Francesca Brett, & John Caird. (2010). Temporal fossa intra-extracranial dumbbell schwannoma. British Journal of Neurosurgery. 25(1). 142–143.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther S.Y. Wong Breakdown of academic impact, for papers by Terje Ahlquist Breakdown of academic impact, for papers by Kimberly A. Scata Breakdown of academic impact, for papers by Shiwu Wu Breakdown of academic impact, for papers by Caroline H. Diep Breakdown of academic impact, for papers by N. Shishido Breakdown of academic impact, for papers by Anna G. Antonacopoulou Breakdown of academic impact, for papers by Marie E. Beckner Breakdown of academic impact, for papers by Alexander Gheldof
Rankless by CCL
2026